ACHFF
Price:
$0.903
Market Cap:
$83.29M
Arch Biopartners Inc., a biotechnology company, develops technologies for medical or commercial impact. It focuses on developing its lead drug candidate Metablok to treat or prevent dipeptidase-1 mediated organ inflammation in the lungs, liver, or kidneys, which results in organ damage or failure, including in the case of sepsis and COVID-19. The company also develops AB569, a drug candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds. In addition, it develops Borg, a peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules that target brain tumor initiati...[Read more]
Industry
Biotechnology
IPO Date
2002-04-24
Stock Exchange
OTC
Ticker
ACHFF
According to Arch Biopartners Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -45.15. This represents a change of -33.14% compared to the average of -67.53 of the last 4 quarters.
The mean historical PE Ratio of Arch Biopartners Inc. over the last ten years is -40.07. The current -45.15 PE Ratio has changed 11.17% with respect to the historical average. Over the past ten years (40 quarters), ACHFF's PE Ratio was at its highest in in the September 2023 quarter at 69.83. The PE Ratio was at its lowest in in the June 2019 quarter at -343.64.
Average
-40.07
Median
-26.02
Minimum
-132.88
Maximum
-12.45
Discovering the peaks and valleys of Arch Biopartners Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 405.38%
Maximum Annual PE Ratio = -12.45
Minimum Annual Increase = -84.60%
Minimum Annual PE Ratio = -132.88
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -28.62 | 39.84% |
| 2023 | -20.47 | -84.60% |
| 2022 | -132.88 | 48.26% |
| 2021 | -89.63 | 405.38% |
| 2020 | -17.73 | -36.07% |
| 2019 | -27.74 | -0.28% |
| 2018 | -27.82 | 123.44% |
| 2017 | -12.45 | -48.78% |
| 2016 | -24.31 | 27.26% |
| 2015 | -19.10 | -9.14% |
The current PE Ratio of Arch Biopartners Inc. (ACHFF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-60.66
5-year avg
-57.87
10-year avg
-40.07
Arch Biopartners Inc.’s PE Ratio is less than Relief Therapeutics Holding AG (-2.06), less than Amplia Therapeutics Limited (-6.86), less than PsyBio Therapeutics Corp. (-0.00), less than Oncotelic Therapeutics, Inc. (-23.15), less than Relief Therapeutics Holding AG (-2.06), less than Helix BioPharma Corp. (-2.46), less than Covalon Technologies Ltd. (23.47), less than Speakeasy Cannabis Club Ltd. (-0.00), less than ZIVO Bioscience, Inc. (-4.50), greater than Vicapsys Life Sciences, Inc. (-62.85),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.06 | $46.28M | |
| -6.86 | $41.56M | |
| -0.00 | $1.27K | |
| -23.15 | $40.10M | |
| -2.06 | $48.32M | |
| -2.46 | $132.13M | |
| 23.47 | $37.56M | |
| -0.00 | $1.31K | |
| -4.50 | $38.89M | |
| -62.85 | $48.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arch Biopartners Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arch Biopartners Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Arch Biopartners Inc.'s PE Ratio?
How is the PE Ratio calculated for Arch Biopartners Inc. (ACHFF)?
What is the highest PE Ratio for Arch Biopartners Inc. (ACHFF)?
What is the 3-year average PE Ratio for Arch Biopartners Inc. (ACHFF)?
What is the 5-year average PE Ratio for Arch Biopartners Inc. (ACHFF)?
How does the current PE Ratio for Arch Biopartners Inc. (ACHFF) compare to its historical average?